1. Viswanatha Reddy M, Jayashankar Reddy V, Ramesh Y, Venkateswarlu I. Research Journal of Pharmaceutical, Biological and Chemical Sciences, 2(3), 2011, 722.
2. El-Kamel, A.H., Sokar, M.S., Al Gamal, S.S., Naggar. Preparation and evaluation of ketoprofen floating oral delivery system. Int J Pharm. 2001; 220, 13-21.
3. Robinson J.R, Lee V.H.L. Controlled drug delivery: fundamentals and applications. 2nd ed. Marcel Dekker Inc; NY 1987.
4. 3.Hirtz J. The git absorption of drugs in man: a review of current concepts and methods of investigation. Br J Clin Pharmacol. 1985;19:77-83.
5. Sangekar S., Evaluation of effect of food and specific gravity of the tablets on gastric retention time. Int.J.Pharm,35(3); 34-53, (1987)
6. Chawla G, Gupta P, Koradia V and Bansal AK., Gastroretention: A Means to Address Regional Variability in intestinal drug Absorption. Pharmaceutical technology, 27(2); 50-68, (2003)
7. Sheth PR and Tossounian J., The Hydrodynamically Balanced System (Hbs™): A Novel Drug Delivery System for Oral Use. Informa healthcare, 10(2); 313- 339, (1984)
8. S. Garg, S. Sharma. Gastroretentive drug delivery system. Business Briefing: Pharmatech. 2003;160-166.
9. Rubinstein, D. R. Friend. Specific delivery to the gastrointestinal tract, in: A. J. Domb (Ed.), polymeric sitespecific Pharmacotherapy. Wiley, Chichester. 1994.282-283.S
10. Ichikawa M, Watanabe S, Miyake Y. A new multiple unit oral floating dosage system. I: Prepration and in vitro evaluation of floating and sustained-release kinetics. J Pharm Sci. 1991; 8:1062-1066.
11. Gu T.H. Pharmacokinetics and pharmacodynamics of diltiazem floating tablets. Chung Kao Yao Li Hsuesh Pao.1992; 13:527-531.
12. Rouge N., Cole E.T., Doelker E., Buri P. Buoyancy and drug release patterns of floating mini tablets containing piretanide and atenolol as model drugs. Pharm. Dev. Technol. 1998; 3:73-84.
13. Cheuh H.R., Zia H., Rhodes C.T. Optimization of Sotalol floating and bioadhesive extended release tablet formulation. Drug Dev. Ind. Pharm. 1995; 21:1725-1747.
14. Nur A.O., Zhang J.S.. Captopril floating and/or bioadhesive tablets: design and release kinetics.Drug Dev Ind Pharm. 2000; 26:965-969.
15. Babu VBM, Khar RK. In vitro and In vivo studies of sustained release floating dosage forms containing salbutamol sulphate. Pharmazie. 1990; 45: 268-270.
16. Hetal N Kikani, A Thesis on, Floating Drug Delivery System, The North Gujarat University, Patan, 2000-2001; 11-12.
17. Babu, V.B.M., Khar, R.K. (1990). In vitro and In vivo studies of sustained release floating dosage forms containing salbutamol sulphate. Pharmazie.; 45: 268-270. PMid:2381979
18. Fell J T, Whitehead L, Collet H, Prolonged gastric trtention using floating dosage forms, Pharm Technol. 2000; 24(3):82-90.
19. Moursy NM, Afifi NH, Ghorab DM, El-Saharty Y. Formulation and evaluation of sustained release floating capsules of Nicardipine hydrochloride. Pharmazie. 2003; 58:38-43.
20. Timmermanns J. and Moes A. (1990). How well do floating dosages forms float? Int.J.Pharm.1987; 62(3): 207 – 216.
21. Chen G.L., Hao W.H., In vitro performance of floating sustained release capsules of verapamil. Drug Dev Ind Pharm.1998; 24:1067-1072.
22. Moursy N.M., Afifi N.N., Ghorab D.M., El- Saharty Y.Formulation and evaluation of sustained release floating capsules of Nicardipine hydrochloride. Pharmazie. 2003; 58:38-43.
23. http://www.pharmabiz.com, Basak S, Chronicle Specials, Floatable Gastroretentives: Emerging Potentials, Mar- 2006.
24. Ritschel W A. Targeting in the gastrointestinal tract: new approaches, methods find. Exp. Clin. Pharmacol. 1991; 13:313-336.
25. Talukder R, Fassihi R. Gastroretentive drug delivery system: A Mini Review. Drug Dev Ind Pharm 2004; 30(10):1019-1028.
26. Klausner EA, Lavy E, Stepensky D, Friedman M, Hoffman A. Novel gastroretentive dosage form: evaluation of gastroretentivity and its effect on riboflavin absorption in dogs. Pharm. Res.2002; 19:1516-1523.
27. Fell J., Digenis C.G. Imaging and behavior of solid oral dosage forms in vivo. Int.J.Pharm.1984; 22(1):1-5.
28. Gansbeke, B.V., Timmermans J., Schoutens A and Moes A.J. Intragastric positioning of two concurrently ingested pharmaceutical matrix dosage forms, Nucl Med Biol.1991;18:711-718.
29. Jao, F., Edgren, D E. and Wong, P S. (2000). Gastric retention dosage form havin multiple layers. Int Application WO0038650.July, 2006.
30. Hendee, W. R. In Textbook of Diagnostic Imaging II, 2nd Ed., W B Saunders, Philadelphia, 1999; 1:1-6.